
Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-05-20 08:01:52Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. This change has prompted an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector.
Read More
Golden Cross Confirmed: Do Divis Laboratories Ltd's Other Technical Indicators Agree?
2026-05-19 18:00:16The 50-day moving average has crossed above the 200-day moving average for Divis Laboratories Ltd, signalling a golden cross on 19 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
06-Aug-2026 | Source : BSESubmission of transcript of Earnings Conference Call held on August 01 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
03-Aug-2026 | Source : BSENewspaper clippings regarding unaudited financial results of the Company for the quarter ended June 30 2026
Announcement under Regulation 30 (LODR)-Change in Management
01-Aug-2026 | Source : BSEAs per enclosed letter.
Corporate Actions
No Upcoming Board Meetings
Divis Laboratories Ltd has declared 1500% dividend, ex-date: 24 Jul 26
Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07
Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15
No Rights history available